idexx lab remain top dog anim diagnost
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
steadili increas scale reach
veterinari diagnost lab busi dig narrow moat
well-posit benefit two key trend first pet ownership
continu grow household own pet
compar moreov pet owner
demonstr greater willing spend anim
tripl spend pet product servic
offer impress wide rang companion anim
diagnost test deliv mani form exampl carv
leadership posit single-us test kit in-offic use
conveni result less minut mani routin
recur diagnost switch outsid lab kit idexx
also maintain strong posit off-sit lab test anoth area
histor seen double-digit growth final enjoy
leadership posit in-hospit analyz focu
develop broaden menu test make
one-stop shop anim hospit uniqu abl
cross-sel mani product servic develop
strong sale organ provid tailor solut
abil sniff opportun build better mousetrap
cross smaller water-test production-animal-test
busi municip often requir routin test
water suppli offer uniqu test detect two
common bacteri contamin easier faster
use tradit test method allow firm
captur water market also
leader livestock poultri diagnost includ test
foot-and-mouth diseas although segment seen
growth robust pet busi gener offer
fatter margin anticip mani year growth ahead
rise incom emerg market feed appetit anim
protein like innov demonstr
expect come
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
idexx laboratori primarili develop manufactur distribut
diagnost product equip servic pet livestock key
product line includ single-us canin felin test kit veterinarian
employ offic benchtop chemistri hematolog analyz
test-panel analysi on-sit refer lab servic test detect
manag diseas livestock get revenu
outsid unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
modestli increas fair valu estim
per share reflect time valu money
continu incorpor optimist assumpt vetlab
consum base recent robust placement analyz
cross-sel opportun also expect double-digit
growth refer lab segment ad
new rout open possibl increas
densiti rout medium term thu
bullish two largest fastest-grow product line
companion anim segment boost
aggress placement instrument steadi
stream new test assay project averag consum
growth also estim
refer lab growth averag per year
begun reap benefit new sale format
focus smaller territori custom contact
nurtur closer relationship vet think
growth sustain bar major pullback
economi consid opportun cross-sel
on-going progress penetr new anim
hospit analyz instrument believ
plenti potenti sale consult sell new
servic develop stickier relationship
meantim continu roll new product
recept companion anim practic expect
averag annual growth companion anim segment
primarili fed adopt seri
new product larger base analyz sale ancillari
servic grow strength consum
refer lab consid adopt curv
in-hous diagnost equip tend slow steadi
sever year benefit string
new product launch deck next five
nonetheless even increas valuat share look
overpr us continu think takeout
premium inflat stock find difficult justifi
share trade revers engin
current share price wed need assum deliv
compound annual top-lin growth
basi point higher idexx three-year
histor compound-annual-growth-rate addit firm would need deliv
basi point improv oper margin
next five year roughli basi point weve
alreadi bake valuat
base larg averag volatil cash flow
divers product portfolio rate uncertainti
base case assum abl expand
busi ahead market
adopt new product strong refer lab
perform drive top-lin growth aid
eas consum discretionari spend
upsid growth companion-anim segment
reach histor mid-double-digit level next
five year -- outpac market roughli basi point
annual --
manufactur effici
attain hike fair valu estim per share
hand companion-anim segment growth
hover rang match long-term growth
pet healthcar market firm slip cost control
key rapid assay kit succumb competit bring
fair valu estim per share
leader point-of-car diagnost test
in-hous analyz equip hold well-establish
posit refer lab duopoli vca part
privat held mar econom moat driven
sever sourc first firm reli intellectu properti
protect know-how goe diagnost test
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equip practic instal base
equip train vet tech practic
like stick switch anoth brand
custom switch cost also rise vet practic
purchas multipl product servic
exampl custom retent notic higher
practic combin refer lab in-hous
analyz softwar integr
final also enjoy cost advantag
diagnost lab extens scale larg
nation lab network abl run test lower
cost thank higher throughput volum ensu
effici use lab result attract margin
smaller-scal independ lab offer
rival vca antech creat duopoli market
built rout network dens
effici element contribut
moat render price tertiari factor
gain scale allow make serial
acquisit new competitor might emerg
seriou threat recent solidifi
posit production-anim segment europ
enter biomed clinic test market
acquisit radil acquir distributor brazil
see moat trend posit sever reason
production-anim diagnost market popul
group smaller pure-play compani pharmaceut
commercial-anim diagnost tini contributor
larger busi think unlik larg pharma
competitor focu much attent market
often seek much bigger profit fish fri
sanofi bayer
abil
consist innov diagnost test firm come
new gener test assay laboratori
equip test diseas appli
emerg diagnost technolog previous invent
human product anim water test well
companion anim product servic
typic focu test new type diseas
parasit improv turnaround time test result
increas accuraci result enhanc
conveni on-sit test firm also offer
integr vet practic manag softwar packag
simplifi transmiss test data patient medic
second moat bolster switch cost across
number product exampl
cornerston practic manag softwar
anim hospit staff invest time enter
patient client inform becom familiar
softwar inconveni instal learn
whole new system mean custom tend stick
principl appli in-hous test
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
continu stream consum revenu
final think bold decis institut all-direct
distribut instrument consum rapid assay
kit histor sold tradit
vet distributor includ henri schein patterson
mwi paid long run although firm requir
increment invest build infrastructur
staff necessari support sale model expect
hold margin profit product
minim risk lose market share competitor
hand small pure play like advanc
anim diagnost could appeal purchas
companion-anim refer lab segment
vca primarili split domest market special
type lab test continu conduct anim
hospit lab associ veterinari school
major bread-and-butt test handl within
duopoli human refer laboratori giant quest
diagnost dip toe anim diagnost market
one refer lab east coast year ago quest
sinc refocus new opportun human
anim diagnost impress record
introduc innov thank robust spend
account estim spend
anim diagnost market made
attract partner pharmaceut firm would like
market therapi along companion
diagnost exampl boehring ingelheim team
market vetmedin treat congest heart failur
dog along cardiopet probnp test
provid earli detect heart failur anim medicin
continu move path pair therapi
diagnost expect highli sought
equip though diagnost test sent
refer lab result within follow two
day turnaround in-hous equip faster
conveni vet practic trade anim
hospit higher-margin in-hous test reap
financi reward even diagnost test
divert refer lab note
make steadi progress persuad practic use
competit in-hous analyz switch idexx
equip grow base instal unit bode well
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ounlik human healthcar pet health servic
reimburs issu price pressur
associ third-parti payer
oanecdot inform vet suggest
well-integr user-friendli practic manag
softwar help hospit switch stick
product servic
oidexx sale custom support staff garner high
mark provid high-touch servic vet practic
ointern sale account substanti chunk
total revenu dollar strengthen
would feel pain top bottom line
oidexx rapid assay product line vulner
competit pressur vet distributor
firm could see growth area stagnat declin
owhil cardiopet probnp seen impress uptak
thu far key veterinari cardiologist held
enthusiast endors vari
interpret test result across dog breed
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi health strong firm histor
fund expans acquisit primarili
cash gener held virtual long-term debt
unlik rival vca mani year ago ran
financi problem increas leverag fund
substanti expans taken financi
conserv approach consid firm throw
free cash flow percentag sale low teen
manag deploy strateg acquisit
share buyback firm decid leverag
balanc sheet increas debt roughli time
debt/ebitda manag target debt remain
rang intent use cash
fund share repurchas think level debt
manag especi consid steadi
cash flow hinder firm flexibl
choos pursu larger acquisit opportun
expect firm end debt/ebitda around time
base larg averag volatil cash flow
divers product portfolio rate uncertainti
medium medic diagnost technolog
remain vulner potenti technolog
consum spend
spend -- show less vet traffic reluct
spend diagnost well vet hold
purchas new upgrad equip
pressur livestock poultri product industri
may translat heighten competit less
negoti leverag time regulatori agenc
chang guidelin livestock poultri test
protein market suffer excess suppli
prolong low price rippl effect part
busi zoeti recent acquisit abaxi could
translat stiffer competit instrument
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
consum
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ceo/chairman board/
repres date owner name posit common share held report holder issuer
new york mellon corp
share
fund
share
fund
think stewardship exemplari ceo
chairman jonathan ayer step role
lead carrier unit unit technolog
seven year fan level detail disclosur
compani provid well preponder
outsid eight-memb board includ lead
director like ceo requir report
success plan board least annual
stock vest five year also impress
ayer exchang cash bonu defer
share ayer equiti stake steadili grown nearli
share outstand -- enough sizabl
stake firm futur opinion ayer approach
compens suggest think act
like owner eye toward long term
hand think share ownership
director remain light would like see boost
stake put skin game
balanc think manag made wise
capital-alloc decis think rack
admir record acquisit made
number purchas make strateg sens
reason price includ bomm diagnost expand
footprint product anim diagnost across europ
dvminsight bolster telemedicin capabl
radil gain foothold biomed research market
perhap
manag will pass deal
opportun enhanc valu asid
merger acquisit like manag
intern
consist upgrad instrument roll new assay
panel importantli partner vet main
critic stewardship focus share
repurchas mainli stock typic bought
premium valuat
staf train
import
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
idexx deliv solid outlook seem
conserv chang fve feb
idexx lab post fourth-quart full-year result
close line expect leav
fair valu estim unchang point despit
slight dip share price manag outlook
struck us somewhat conserv leav project
year high end manag rang
recogn foreign exchang headwind could strengthen
come quarter would lead us revisit
estim nonetheless sinc valu
long period time type exchang adjust
given year often immateri valuat
see littl reason shift think idexx narrow
econom moat firm continu introduc
saw idexx fourth quarter fairli
typic firm total quarterli revenu
organ fuel low-teen growth companion
anim diagnost segment pleas see
proport total sale -- basi point sinc firm
move all-direct distribut late think
shift larg respons
improv gross margin sinc effort began
condit dont anticip major disrupt
spend pet healthcar
quarter aberr well keep eye
head first half
despit temper expect
hold steadi fve
typic compani post anoth strong
quarter double-digit organ revenu growth fuel
companion anim busi year date firm
perform line close full-year project
hold steadi fair valu estim narrow-
moat consist outpac market growth anim
healthcar thank comprehens portfolio multipl
modal diagnost test high level custom
servic dynam underscor high
proport idexx catalyst new
competit account proport even higher
north america segment zoeti acquir
key diagnost rival abaxi longer keep tab
well instrument placement go nonetheless
specul process integr zoeti
may caus distract abaxi
commerci organ allow press
advantag expans
instal base
instrument remain critic driver benchtop
diagnost busi larger base translat
recur revenu stream higher-margin consum
third quarter saw vetlab consum grow
howev discern potenti red flag idexx fourth-
quarter survey data suggest could
slowdown vet offic traffic usual season
pattern see vet offic visit heavier
second third quarter weather warm first
quarter histor weakest quarter due winter
fourth quarter late vet offic
traffic lighter first quarter may simpli one
see littl quarter chang view
idexx long-term prospect share pull back
manag trim high side outlook
full year havent made materi chang
assumpt manag revis lower
rang expect estim
high side rang howev recogn
share trade lofti level partli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
expect potenti take-out perspect
even slight pullback share remain
substanti intrins valu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
